Further investigations in a number of laboratories have suggested other drugs/treatments that would/could treat HGPS—these include the N-acetyl cysteine, free radical scavenger (Richards et al. 2011), rapamycin—the new anti-ageing treatment (Cao et al. 2011b; Cenni et al. 2012; Graziotto et al. 2016; Evangelisti et al. 2016), and IGF-1 (Mariño et al. 2010). The gene discussed is IGF1; the disease is Hutchinson-Gilford progeria syndrome.